For citations:
Alekseev S.M., Kaplanov K.D., Ivanov R.A., Chernyaeva E.V. CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®. Research and Practical Medicine Journal. 2015;2(1):8-12. (In Russ.) https://doi.org/10.17709/2409-2231-2015-2-1-8-12
Email this article 